Managed Healthcare Executive – CAR T-cell Therapies in Treating Lymphoma: Pros and Cons

News RSS

Catherine Bollard, MD, professor of pediatrics and of microbiology, immunology, and tropical medicine, spoke to Managed Healthcare Executive for an article about CAR T-cells and her presentation at the 2017 American Society of Hematology annual meeting.

Read More

click
tracking
Share
Share